1-20 of 117 results for subject:"Macfarlane Trust"
Librarians' tools
- Search time
- 0.435 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:"Macfarlane Trust"
- We searched for
- subject_t:"Macfarlane Trust" OR subject_ses:43915
Type
House
Session
Year
Department
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of people who were registered with the Macfarlane Trust but (a) never applied for and (b) were unsuccessful in applying for Skipton Stage 1 payments.
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of people who were registered with the Macfarlane Trust but (a) never applied for and (b) were unsuccessful in applying for Skipton Stage 1 payments.
No estimate has been made as the Department does not hold the relevant personal data on those registered with the Macfarlane Trust.
To ask the Secretary of State for Health and Social Care, what consultations his Department held with beneficiaries of the Macfarlane Trust prior to the closure of that Trust and transfer of that Trust's residual funds and assets to the Terrence Higgins Trust.
To ask the Secretary of State for Health and Social Care, what consultations his Department held with beneficiaries of the Macfarlane Trust prior to the closure of that Trust and transfer of that Trust's residual funds and assets to the Terrence Higgins Trust.
The Department launched the first infected blood consultation, ‘Infected blood: reform on financial and other support’1, in January 2016. The consultation confirmed that the majority of beneficiaries would prefer one scheme to the then five schemes. The second consultation ‘Infected blood: Consultation on Special Category Mechanism and financial and other support in England’2 in October 2017 announced that NHS Business Services Authority, not the former scheme administrators, such as the Macfarlane Trust, would manage the new reformed scheme.
I have written to the Macfarlane Trust on a number of occasions since 12 September 2018 asking for its plans with respect to any residual funds it held on closure. I also reminded the Macfarlane Trust that it must operate in accordance with its trust deed which states that the funds can only be transferred to one or more bodies established for charitable purposes with similar, or the same, objectives to its own i.e. providing support for people infected with HIV. The Macfarlane Trust informed me of the transfer of the its residual funds and assets to the Terrence Higgins Trust via a letter dated 12 December 2018. Consultation with beneficiaries regarding this transfer of assets on closure was not the responsibility of the Department.
Notes:
1https://www.gov.uk/government/consultations/infected-blood-reform-of-financial-and-other-support
2https://www.gov.uk/government/consultations/infected-blood-support-special-category-mechanism
To ask the Secretary of State for Health, how much funding his Department will provide to (a) the Macfarlane Trust, (b) the Caxton Foundation and (c) the Eileen Trust beyond 1 April 2017.
To ask the Secretary of State for Health, how much funding his Department will provide to (a) the Macfarlane Trust, (b) the Caxton Foundation and (c) the Eileen Trust beyond 1 April 2017.
We will continue to fund the three discretionary payment support schemes beyond 1 April 2017. However, we are not yet able to confirm at this stage what the funding amount will be for the three charities. We are committed to continuing with discretionary funding.
The NHS Business Services Authority (NHS-BSA) is being appointed to provide support to all beneficiaries of the schemes later in 2017. We do not anticipate the NHS-BSA will receive an increase in running costs to administer the new scheme than is currently being provided to the existing schemes. It is important that any allocation to the new arrangement does not impact or compromise on support to beneficiaries. The overall allocation for the schemes, irrespective of provider, remains at £231 million for the period of the current Spending Review.
To ask the Secretary of State for Health, whether his Department has received a request for further funding from the (a) Macfarlane Trust and (b) Caxton Foundation infected blood scheme administrators beyond the 2017-18 fiscal year.
To ask the Secretary of State for Health, whether his Department has received a request for further funding from the (a) Macfarlane Trust and (b) Caxton Foundation infected blood scheme administrators beyond the 2017-18 fiscal year.
The five existing support schemes (Skipton Fund Ltd, MFET Ltd, Macfarlane Trust, Eileen Trust and Caxton Foundation) will remain in place and be able to make payments to its beneficiaries, until the new scheme administrator is in place.
To ask the Secretary of State for Health, whether his Department's (a) £10 million payment to the Macfarlane Trust in 1987 and (b) £500,000 payment to the Eileen Trust in 1993 was allocated to his Department's capital budget or revenue budget.
To ask the Secretary of State for Health, whether his Department's (a) £10 million payment to the Macfarlane Trust in 1987 and (b) £500,000 payment to the Eileen Trust in 1993 was allocated to his Department's capital budget or revenue budget.
The Department does not hold the information requested.
The Department only holds data for the last seven financial years, in accordance with departmental policy for retention of financial data, and the Finance Act 1998 - Schedule 18 Part III, Duty to keep and preserve records.
The government spending control regime has changed many times since the period referred to in the question, however generally payments to charities such as these would score as “grants”. The treatment of a grant as “revenue” or “capital” is explained on page 31 of HM Treasury’s Consolidated Budgeting Guidance 2016-17, which can be found at:
To ask the Secretary of State for Health, whether the current scheme of discretionary top-up payments provided by the Macfarlane Trust to its beneficiaries will be removed as a result of the Government's proposed changes to its scheme of support for people affected by contaminated blood.
To ask the Secretary of State for Health, whether the current scheme of discretionary top-up payments provided by the Macfarlane Trust to its beneficiaries will be removed as a result of the Government's proposed changes to its scheme of support for people affected by contaminated blood.
The consultation on reforming the current payment schemes for those affected by HIV and/or hepatitis C through National Health Service-supplied blood/blood products closed on 15 April. The analyses of responses are still being considered by Ministers and no decisions on changes to the schemes have been taken. An announcement will be made in due course.
To ask the Secretary of State for Health, how many staff are employed by the (a) Macfarlane Trust and (b) Caxton Foundation; and what their (i) posts and (ii) current salaries are.
To ask the Secretary of State for Health, how many staff are employed by the (a) Macfarlane Trust and (b) Caxton Foundation; and what their (i) posts and (ii) current salaries are.
The amount of time that each member of staff spends working on either Macfarlane Trust business or Caxton Foundation business is given in the following table:
| % of time spent on Caxton Foundation | % of time spent on Macfarlane Trust |
Chief Executive | 48 | 48 |
Director of Finance | 27 | 27 |
Finance Assistant | 32 | 32 |
Director of Operations | 47 | 47 |
Support Services Officer | 0 | 100 |
Welfare Assistant | 100 | 0 |
Office Manager | 50 | 50 |
IT Manager | 13 | 13 |
The Caxton Foundation cannot provide details of the salaries of these individuals because salaries are personal information under section 1 of the Data Protection Act 1998. However, as with all charities, the pay bands of the highest paid members of staff are a matter of public record. The Caxton Foundation’s annual report and accounts for 2013-14, state that one member of staff received a salary in the pay band of £70,001 - £80,000. That salary was paid in respect of work for both the Caxton Foundation and the Macfarlane Trust. All employees of who were employed at 1 April 2014 received a 1% salary increase. That is the only pay increase that the Chief Executive has received since her appointment in 2013.
To ask the Secretary of State for Health, how many people were registered with (a) the Macfarlane Trust, (b) the Skipton Fund and (c) the Caxton Foundation in each year since 2011.
To ask the Secretary of State for Health, how many people were registered with (a) the Macfarlane Trust, (b) the Skipton Fund and (c) the Caxton Foundation in each year since 2011.
The number of people registered with the Macfarlane Trust, the Skipton Fund and the Caxton Foundation, from 2011-12 to the most recent full year for which the Department has figures are as follows:
| 2011-12 | 2012-13 | 2013-14 |
Skipton Fund | 4,908 | 5,038 | 5,132 |
Caxton Foundation | 505 | 555 | 695 |
Macfarlane Trust | 549 | 608 | 599 |
The Skipton Fund figures relate to successful stage 1 applications in respect of infected claimants, but it is not known how many of these people are currently still alive. The Caxton Foundation and Macfarlane Fund figures are the number of living beneficiaries at 31 March in each of the specified years, and includes both infected and uninfected beneficiaries.
To ask the Secretary of State for Health, what change there has been in the salary of the Chief Executive of the Macfarlane Trust and Caxton Foundation since her appointment in 2013.
To ask the Secretary of State for Health, what change there has been in the salary of the Chief Executive of the Macfarlane Trust and Caxton Foundation since her appointment in 2013.
The amount of time that each member of staff spends working on either Macfarlane Trust business or Caxton Foundation business is given in the following table:
| % of time spent on Caxton Foundation | % of time spent on Macfarlane Trust |
Chief Executive | 48 | 48 |
Director of Finance | 27 | 27 |
Finance Assistant | 32 | 32 |
Director of Operations | 47 | 47 |
Support Services Officer | 0 | 100 |
Welfare Assistant | 100 | 0 |
Office Manager | 50 | 50 |
IT Manager | 13 | 13 |
The Caxton Foundation cannot provide details of the salaries of these individuals because salaries are personal information under section 1 of the Data Protection Act 1998. However, as with all charities, the pay bands of the highest paid members of staff are a matter of public record. The Caxton Foundation’s annual report and accounts for 2013-14, state that one member of staff received a salary in the pay band of £70,001 - £80,000. That salary was paid in respect of work for both the Caxton Foundation and the Macfarlane Trust. All employees of who were employed at 1 April 2014 received a 1% salary increase. That is the only pay increase that the Chief Executive has received since her appointment in 2013.
To ask the Secretary of State for Health what his plans are for future funding of the Macfarlane Trust; and if he will make a statement.
[152626]
To ask the Secretary of State for Health what his plans are for future funding of the Macfarlane Trust; and if he will make a statement.
[152626]
Allocations to the Macfarlane Trust are decided on an annual basis. This year we have made available an allocation of up to £2.2 million. In addition, the Trust is holding funds of about £3.5 million in reserve, which it is able to disburse to its beneficiaries.
Letter dated 28/06/2011 from Earl Howe to Lord Morris regarding patients infected with hepatitis C by contaminated NHS supplied blood. 1 p.
Letter dated 28/06/2011 from Earl Howe to Lord Morris regarding patients infected with hepatitis C by contaminated NHS supplied blood. 1 p.
To ask Her Majesty’s Government, further to the statement by Earl Howe on 10 January concerning infected blood (HL Deb, cols 1229–32), what are the numbers and average level of additional discretionary payments made by the Eileen Trust and the Macfarlane Trust to applicants infected with HIV; and what is...
To ask Her Majesty’s Government, further to the statement by Earl Howe on 10 January concerning infected blood (HL Deb, cols 1229–32), what are the numbers and average level of additional discretionary payments made by the Eileen Trust and the Macfarlane Trust to applicants infected with HIV; and what is...
Lords statement on hepatitis C and HIV infected blood.
Lords statement on hepatitis C and HIV infected blood.
My Lords, I have two interests to declare, both non-pecuniary: as president of the Haemophilia Society, and as the architect of the independent public inquiry into the contaminated blood disaster headed by my noble and learned friend Lord Archer of Sandwell. Is the Minister aware that, of the 1,241 haemophilia...
My Lords, I have two interests to declare, both non-pecuniary: as president of the Haemophilia Society, and as the architect of the independent public inquiry into the contaminated blood disaster headed by my noble and learned friend Lord Archer of Sandwell. Is the Minister aware that, of the 1,241 haemophilia...
My Lords, perhaps I may start by wishing the Minister and other noble Lords a very happy new year and by commending the Minister for his patience: he finally got to make the Statement. I welcome the Statement and congratulate the Minister and his colleagues on making progress in building...
My Lords, perhaps I may start by wishing the Minister and other noble Lords a very happy new year and by commending the Minister for his patience: he finally got to make the Statement. I welcome the Statement and congratulate the Minister and his colleagues on making progress in building...
My Lords, I am heartened by and grateful for the welcome given by the noble Baroness to this Statement and the package of support that was announced in it. We think that it represents a fair and reasonable recognition of the suffering that many of these victims endure. We wanted...
My Lords, I am heartened by and grateful for the welcome given by the noble Baroness to this Statement and the package of support that was announced in it. We think that it represents a fair and reasonable recognition of the suffering that many of these victims endure. We wanted...
My Lords, I should now like to repeat a Statement made earlier by my right honourable friend the Secretary of State for Health in another place. The Statement is as follows. ““With permission, I should like to make a Statement on hepatitis C and HIV infected blood. Mr Speaker, what...
My Lords, I should now like to repeat a Statement made earlier by my right honourable friend the Secretary of State for Health in another place. The Statement is as follows. ““With permission, I should like to make a Statement on hepatitis C and HIV infected blood. Mr Speaker, what...
My Lords, I congratulate my noble friend the Minister on the package announced in the Statement today. We very much welcome both it and, as the noble Baroness, Lady Thornton, said, the huge progress that has been made. Given that the commitment to review the current arrangements was made just...
My Lords, I congratulate my noble friend the Minister on the package announced in the Statement today. We very much welcome both it and, as the noble Baroness, Lady Thornton, said, the huge progress that has been made. Given that the commitment to review the current arrangements was made just...
My Lords, the noble Lord, Lord Morris of Manchester, to whose efforts I pay particular tribute in the context of this debate, as in many other contexts, has reminded us of the devastating effect of this tragedy on individuals and families. The previous Government recognised this and significantly improved the...
My Lords, the noble Lord, Lord Morris of Manchester, to whose efforts I pay particular tribute in the context of this debate, as in many other contexts, has reminded us of the devastating effect of this tragedy on individuals and families. The previous Government recognised this and significantly improved the...
I am very grateful to my noble friend. The window of opportunity referred to in the Statement—until the end of March, which is the best part of three months—should be sufficient to enable those with a valid claim to come forward. On the whole, we believe that, in the haemophiliac...
I am very grateful to my noble friend. The window of opportunity referred to in the Statement—until the end of March, which is the best part of three months—should be sufficient to enable those with a valid claim to come forward. On the whole, we believe that, in the haemophiliac...